Skip to main content
SpringerLink
Log in

Lokal fortgeschrittenes Rektumkarzinom

Macht eine neoadjuvante Chemotherapie die Strahlentherapie verzichtbar?

  • Journal club
  • Published:
Gastro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Folkesson J et al. J Clin Oncol. 2005;23:5644-50

  2. Bahadoer RR et al. Lancet Oncol. 2021;22:29-42

  3. Garcia-Aguilar J et al. J Clin Oncol. 2022;40:2546-56

  4. Cercek A et al. N Engl J Med. 2022;386:2363-6

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin II, Universitätsklinikum Freiburg, Hugstetter Straße 55, 79106, Freiburg, Germany

    Annegrit Decker Oberärztin & Lioba Klaas Ärztin

Authors
  1. Annegrit Decker Oberärztin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lioba Klaas Ärztin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lioba Klaas Ärztin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Decker, A., Klaas, L. Macht eine neoadjuvante Chemotherapie die Strahlentherapie verzichtbar?. Gastro-News 10, 28–30 (2023). https://doi.org/10.1007/s15036-023-3288-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15036-023-3288-x

Search

Navigation